Innate Pharma (IPHA) — Cash Flow-to-Debt Ratio
Innate Pharma (IPHA) has a Cash Flow-to-Debt Ratio of -0.28x as of March 2026, meaning its operating cash flow of $-23.40 Million could theoretically repay 0% of its total liabilities ($84.39 Million) in one year. See how financially flexible is Innate Pharma to measure the company's free cash flow as a share of total liabilities.
CF-to-Debt Ratio
Operating Cash Flow
Total Liabilities
Data as of
Innate Pharma Cash Flow-to-Debt Ratio (2005–2025)
Historical debt coverage capacity for Innate Pharma across 21 annual periods. For the full cash flow conversion analysis, see Innate Pharma (IPHA) cash conversion ratio.
Annual Cash Flow-to-Debt Ratio for Innate Pharma (2005–2025)
Year-by-year debt coverage analysis for Innate Pharma. Check Innate Pharma earnings quality ratio to evaluate the quality of earnings relative to operating cash generation.
| Year | CF-to-Debt Ratio | Operating CF (USD) | Total Liabilities | YoY Change |
|---|---|---|---|---|
| 2025 | -0.60x | $-50.67 Million | $84.39 Million | ▼ -790.1% |
| 2024 | -0.07x | $-6.90 Million | $102.22 Million | ▲ +72.6% |
| 2023 | -0.25x | $-32.56 Million | $132.29 Million | ▼ -97.5% |
| 2022 | -0.12x | $-19.15 Million | $153.71 Million | ▲ +65.9% |
| 2021 | -0.37x | $-58.46 Million | $160.06 Million | ▼ -6.8% |
| 2020 | -0.34x | $-51.81 Million | $151.45 Million | ▼ -280.2% |
| 2019 | 0.19x | $34.92 Million | $183.94 Million | ▲ +265.7% |
| 2018 | -0.11x | $-32.53 Million | $283.98 Million | ▲ +59.7% |
| 2017 | -0.28x | $-48.06 Million | $169.07 Million | ▼ -50.7% |
| 2016 | -0.19x | $-36.85 Million | $195.41 Million | ▼ -121.2% |
| 2015 | 0.89x | $207.91 Million | $233.89 Million | ▲ +178.7% |
| 2014 | -1.13x | $-18.13 Million | $16.06 Million | ▼ -60.5% |
| 2013 | -0.70x | $-10.97 Million | $15.60 Million | ▼ -67.4% |
| 2012 | -0.42x | $-10.47 Million | $24.93 Million | ▼ -208.3% |
| 2011 | 0.39x | $12.99 Million | $33.48 Million | ▲ +141.8% |
| 2010 | -0.93x | $-13.45 Million | $14.49 Million | ▼ -167.3% |
| 2009 | -0.35x | $-5.94 Million | $17.10 Million | ▲ +54.0% |
| 2008 | -0.76x | $-14.74 Million | $19.52 Million | ▼ -10.2% |
| 2007 | -0.69x | $-9.28 Million | $13.55 Million | ▼ -2552.5% |
| 2006 | 0.03x | $360.00K | $12.89 Million | ▲ +101.8% |
| 2005 | -1.54x | $-7.25 Million | $4.70 Million | — |